The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma. - Deng, Wei; Xie, Jin; Wang, Tao; Luo, Laihui; Zhu, Guoqing; Xiao, Yongqiang; Tao, Jiahao; Lin, Liucong; Ge, Xian; Wen, Wu; Wang, Minglong; Yu, Bin; et al. (BMC Cancer, 2025)